Imagion Biosystems Limited
ASX:IBX.AX
0.023 (AUD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.083 | 0.473 | 0.233 | 0.206 | 0.411 | 0.191 | 0.02 | 0 | 0.005 | 0.006 |
| Cost of Revenue
| 5.251 | 3.616 | 2.704 | 2.861 | 2.269 | 3.296 | 0 | 0.022 | 0 | 0 |
| Gross Profit
| -4.168 | -3.142 | -2.471 | -2.655 | -1.858 | -3.104 | 0.02 | -0.022 | 0.005 | 0.006 |
| Gross Profit Ratio
| -3.848 | -6.638 | -10.612 | -12.906 | -4.523 | -16.212 | 1 | -1,802.5 | 1 | 1 |
| Reseach & Development Expenses
| 5.251 | 3.616 | 2.704 | 2.861 | 2.269 | 3.296 | 2.156 | 0.502 | 3.885 | 2.239 |
| General & Administrative Expenses
| 6.702 | 5.517 | 3.759 | 2.823 | 1.817 | 3.965 | 2.724 | 0.514 | 0.246 | 0.087 |
| Selling & Marketing Expenses
| 6.702 | 0 | 0 | 0 | 0 | 0 | 0 | -0.471 | 0 | 0 |
| SG&A
| 10.284 | 5.517 | 3.759 | 2.823 | 1.817 | 3.965 | 2.724 | 0.043 | 0.246 | 0.087 |
| Other Expenses
| 3.935 | 3.57 | 2.407 | 2.272 | 1.795 | 1.888 | 0.237 | 0 | 0 | 0 |
| Operating Expenses
| 15.534 | 12.702 | 8.87 | 7.956 | 5.881 | 9.149 | 7.198 | 0.545 | 4.13 | 2.326 |
| Operating Income
| -15.635 | -9.805 | -6.02 | -5.358 | -3.423 | -8.332 | -6.859 | -0.567 | -4.125 | -2.319 |
| Operating Income Ratio
| -14.437 | -20.711 | -25.854 | -26.043 | -8.332 | -43.516 | -341.227 | -47,214.167 | -751 | -379.6 |
| Total Other Income Expenses Net
| -0.373 | -0.002 | -0.004 | -0.006 | -0.009 | -0.008 | 0.237 | -0.468 | -0.276 | -0.196 |
| Income Before Tax
| -16.008 | -9.807 | -6.025 | -5.364 | -3.433 | -8.34 | -7.795 | -1.034 | -4.401 | -2.515 |
| Income Before Tax Ratio
| -14.782 | -20.715 | -25.872 | -26.075 | -8.355 | -43.556 | -387.753 | -86,206.417 | -801.25 | -411.6 |
| Income Tax Expense
| -3.534 | 0.002 | 2.615 | 2.431 | 2.034 | 0.008 | 0.935 | -0 | 0 | 0 |
| Net Income
| -12.474 | -9.809 | -8.639 | -7.795 | -5.466 | -8.348 | -7.795 | -1.034 | -4.401 | -2.515 |
| Net Income Ratio
| -11.519 | -20.719 | -37.1 | -37.892 | -13.304 | -43.597 | -387.753 | -86,206.417 | -801.25 | -411.6 |
| EPS
| -0.41 | -0.35 | -0.33 | -0.42 | -0.61 | -0.036 | -0.043 | -0.01 | -214.69 | -122.69 |
| EPS Diluted
| -0.41 | -0.35 | -0.33 | -0.42 | -0.61 | -0.036 | -0.043 | -0.01 | -214.68 | -122.68 |
| EBITDA
| -14.452 | -8.697 | -5.616 | -4.997 | -3.281 | -8.118 | -6.653 | -0.545 | -3.97 | -2.272 |
| EBITDA Ratio
| -13.345 | -18.37 | -24.117 | -24.29 | -7.987 | -42.399 | -330.937 | -45,410.833 | -722.75 | -371.8 |